Vir Biotechnology Inc (VIR) — Cash Flow Quality Index
Vir Biotechnology Inc (VIR) has a Cash Flow Quality Index of 0.67x as of September 2022. Operating cash flow of $117.90 Million is below net income of $175.31 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore investment intensity of Vir Biotechnology Inc to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vir Biotechnology Inc Cash Flow Quality Index (2021–2022)
Historical Cash Flow Quality Index for Vir Biotechnology Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check VIR tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Vir Biotechnology Inc (2021–2022)
Year-by-year earnings quality comparison for Vir Biotechnology Inc. For live market cap and the full company financial profile, see Vir Biotechnology Inc (VIR) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 3.22x | $1.66 Billion | $515.84 Million | ▲ +3681.4% |
| 2021 | -0.09x | $-47.59 Million | $528.58 Million | — |